Andrew Dreyfus - 15 Dec 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 15:05:27 UTC
Previous filing
17 Sep 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1,431 +1.1% $0.000000 130,077 15 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Director Compensation Policy, effective as of May 2019.
F2 Since the date of the reporting person's last ownership report, the individual transferred 6,014 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.

Remarks:

Exhibit 24: Power of Attorney